Screening using BNP may prevent heart failure, study says

03/13/2013 | MedPage Today (free registration)

Screening patients at risk for heart failure but without symptoms, and then beginning treatment based on B-type natriuretic peptide levels, reduced the risk of hospitalization for heart failure and left ventricular dysfunction, according to a study from University Hospital in Dublin presented at the American College of Cardiology meeting. Researcher Dr. Kenneth McDonald said the study shows that BNP screening could have "a significant impact on the development of new-onset heart failure."

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA